MSD Animal Health, a division of Merck & Co., Inc., is a leading player in the global animal health industry, headquartered in the United Kingdom. Established in 1891, the company has a rich history of innovation and commitment to animal welfare, with significant operational regions across Europe, North America, and Asia. Specialising in vaccines, pharmaceuticals, and diagnostic tools, MSD Animal Health offers a comprehensive portfolio designed to enhance the health and productivity of livestock and companion animals. Their unique approach combines cutting-edge research with a deep understanding of animal care, positioning them as a trusted partner in veterinary medicine. With a strong market presence, MSD Animal Health has achieved numerous milestones, including advancements in disease prevention and treatment. Their dedication to sustainability and animal health continues to set them apart in a competitive landscape, making them a preferred choice for veterinarians and animal owners alike.
How does MSD Animal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MSD Animal Health's score of 62 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MSD Animal Health, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Merck & Co., Inc., which influences its climate commitments and initiatives. As a current subsidiary, MSD Animal Health inherits sustainability targets and initiatives from Merck & Co., Inc. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across their operations. The specific reduction targets and achievements for MSD Animal Health are not detailed, but they align with the broader goals set by their parent company. Merck & Co., Inc. has established significant climate commitments, which may cascade down to MSD Animal Health, focusing on reducing Scope 1, 2, and 3 emissions. These initiatives reflect a commitment to sustainability and responsible environmental stewardship within the animal health sector. In summary, while specific emissions data for MSD Animal Health is not available, the company is positioned within a framework of robust climate commitments inherited from Merck & Co., Inc., aiming for a sustainable future in alignment with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 417,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 367,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 64,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MSD Animal Health is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.